Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the January issue! There will be another recession – as certain as night follows day – but, our cover feature asks, how bad will it be? And is the pharma industry prepared? In Upfront, we explore how digital tech is fighting fake medicine, and how computer simulations are improving ADC linkers. Araksya Topchyan highlights the importance of drug-nutrient interactions in In My View; while NextGen asks: what happens if you try to apply open source to pharmaceutical R&D? Last but not least, we Sit Down With Jane Osbourn, Chair at Mogrify and the UK BioIndustry Association.